Rephonic
Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers
Multiple Myeloma
Myelofibrosis
Chronic Lymphocytic Leukemia
Colorectal Cancer
Hepatocellular Carcinoma
FDA
Radiation Oncology
Stereotactic Body Radiation Therapy
Liver Cancer
Triple Negative Breast Cancer
Transarterial Chemoembolization
Interventional Radiology
Socioeconomic Disparities
Racial Disparities
Blood Cancers
Anemia
Stem Cell Transplant
JAK Inhibitors
Thrombocytopenia
MD Anderson Cancer Center

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and ... more

PublishesTwice weeklyEpisodes100Founded3 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Oncology Brothers: Practice-Changing Cancer Discussions

Latest Episodes

In this episode of the Oncology Brothers podcast, we discussed two challenging cases focused on Acute Myeloid Leukemia (AML). We welcomed Dr. Naval Daver, a leading expert from MD Anderson Cancer Center, to discuss: therapy-related AML and de novo AM... more

In this episode of the Oncology Brothers podcast, we dived into the current treatment landscape for head and neck cancer. We welcomed Dr. Fangdi Sun, a head and neck medical oncologist from Stanford University, to discuss key topics including:

• The... more

In this episode of the Oncology Brothers podcast, we dived into the recent FDA approval of daratumumab for high-risk smoldering myeloma, based on the groundbreaking AQUILA study. We were joined by Dr. Vincent Rajkumar, a world-renowned myeloma specia... more

Feeling overwhelmed by the rapid pace of change in multiple myeloma? ASH 2025 delivered potentially practice-changing data that could redefine second-line therapy and beyond.

In this episode, we sat down with myeloma specialist Dr. Ben Derman from t... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Fangdi Sun
Head and neck medical oncologist at Stanford University
Stanford University
Episode: Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun
Vincent Rajkumar
Lead author and world-renowned myeloma specialist
Episode: FDA Approval of Daratumumab in High Risk Smoldering Myeloma: AQUILA by Dr. Vincent Rajkumar
Ben Derman
Myeloma specialist from University of Chicago
University of Chicago
Episode: ASH 2025 Multiple Myeloma Highlights – AQUILA, COBRA, TecLILLE, MajesTEC-3: Dr. Ben Derman
Dr. Rachna Shroff
A leading oncologist from University of Arizona Cancer Center
University of Arizona Cancer Center
Episode: GI ASCO 2026 Highlights MATTERHORN, HERIZON-GEA-01, BREAKWATER, COMMIT – Dr. Rachna Shroff
Dr. Julie Vose
A leader in lymphoma from the University of Nebraska Medical Center
University of Nebraska Medical Center
Episode: ASH 2025 Lymphoma Highlights - EPCORE FL-1, CLL-17, BRUIN CLL-313, SWOG-1826: Dr. Julie Vose
Dr. Jorge Cortes
Clinical expert from Georgia Cancer Center
Georgia Cancer Center
Episode: ASH 2025 Leukemia Highlights PARADIGM, KOMET-007, ASC4FIRST, ASC2ESCALATE - Dr. Jorge Cortes
Dr. Harold Burstein
Oncologist at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein
Rebecca Shatsky
Breast medical oncologist and Director of the Inflammatory and Triple Negative Breast Cancer Program at UC San Diego
UC San Diego
Episode: Triple Negative Breast Cancer SABCS 2025 Highlights: Dr. Rebecca Shatsky
Thomas Powles
World-renowned GU medical oncologist
Episode: Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles

Hosts

Rahul Gosain
Co-host specializing in oncology, dedicated to bridging the gap between academic research and practical application in community settings.
Rohit Gosain
Co-host focused on providing oncologists with practical insights and expert discussions on cancer care advancements.

Reviews

4.8 out of 5 stars from 87 ratings
  • Oncology Brothers: Setting a New Standard in Medical Education

    The Oncology Brothers have become a go-to in my week. They take the constant firehose of oncology data—new FDA approvals, shifting algorithms, and “practice-changing” abstracts—and turn it into something practical I can actually use in clinic the next day. The conversations feel like sitting down with smart colleagues who care about evidence, clarity, and real-world decision making, not just reciting trial slides. It’s exactly the kind of thoughtful, high-yield education our field needs more of.... more

    Apple Podcasts
    5
    DD1384
    United States23 days ago
  • Excellent Resource

    I regularly listen to this podcast and find it an excellent reference for oncology practice. The speakers consistently provide valuable insights that are both practical and informative. It's a great resource for staying updated and enhancing clinical knowledge.

    Apple Podcasts
    5
    RHJ, MD
    United States7 months ago
  • Insightful, relatable, and essential for anyone in the oncology community

    The Oncology Brothers consistently deliver relevant, easy-to-digest insights on complex data and evolving treatment landscapes. Their ability to break down key updates—especially for those who can't attend every conference—is incredibly valuable. A must-listen for anyone in oncology looking to stay current and connected to the community.

    Apple Podcasts
    5
    OncoScriber
    United States7 months ago
  • Stage IV CRC

    Thank you so much for putting this together! Love the updates of ongoing research! I am the primary caretaker for my 79 year old dad who was diagnosed 6/24 with stage IV CRC MSS KRAS G13D TMB-H, so love your GI updates from ASCO ‘25 and subcutaneous nivo, which we are considering. Hope you do more like bot/bal and neodadjuvant single cycle pembro. Thanks for taking the time to do this!!

    Apple Podcasts
    5
    mama4travel
    United Statesa year ago
  • Onc Doc in the communty

    I have been following your content on X/Twitter and now I love that I can access these interviews here. Great work, much appreciated when things are moving so fast in this field.

    Apple Podcasts
    5
    Jimzz24
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the concise and practical information that enhances their clinical practices.
Audience members find the guest experts informative and relevant, improving their understanding of patient care.
Many users highlight the pedagogical approach, making complex oncology topics understandable.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

ASH 2025 Lymphoma Highlights - EPCORE FL-1, CLL-17, BRUIN CLL-313, SWOG-1826: Dr. Julie Vose
Q: Julie, can you please touch on the study design and what we saw as findings?
Julie outlines the Epcor FL1 study methodology and discusses its significant findings.
HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein
Q: What are we seeing here? And if this was to get approved in an adjuvant setting, what are we doing here?
Burstein highlights that DESTINY Breast-05 is practice-defining, showing TDXD's superiority over TDM-1 in patients with residual disease after standard therapies.
HER2+ SABCS 2025 Highlights DESTINY Breast-05/Breast-11, HER2CLIMB-05, PATINA: Dr. Harold Burstein
Q: Can you please touch into study designs and its findings? And importantly, who would be that right patient in your clinic today that will potentially get this over TCHV?
Dr. Burstein explains the trial designs involving TDXD and discusses its efficacy in high-risk HER2-positive breast cancer patients.
Early HR+ Disease SABCS 2025 Practice Changing/Informing Highlights: ALTTO, lidERA, NATALEE
Q: If gerodestrant was to become available today, what practice would you adopt when CDK4-6 inhibitors are also indicated?
I would likely sequence AI with CDK4-6 inhibitors first and then transition to gerodestrant once the initial treatment period is completed.
Current Treatment Landscape of Advanced Gastric/Esophageal/GEJ Adenocarcinoma – Dr. Rutika Mehta
Q: What happens if HER2 status changes upon retesting after progression?
Retesting is important as HER2 expression can be lost over time. If a patient is retested and becomes HER2 negative, treatment plans must adapt accordingly to ensure they are receiving the most appropriate therapy.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

The focus is on providing concise and engaging discussions centered around advancements and strategies in oncology, targeting common cancers including breast, prostate, kidney, bladder, lung, and gastrointestinal cancers. Each episode features insights from esteemed oncologists and researchers, presenting the latest FDA approvals, treatment protocols, and practical data that can be utilized within everyday clinical practices. The incorporation of visual aids enhances understanding and application of complex data, making it a valuable resource for medical professionals seeking to improve patient care and stay updated in the rapidly evolving oncology landscape.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Research To Practice | Oncology Videos
4. ASCO Guidelines
5. ASCO Daily News

How many episodes of this podcast are there?

this podcast launched 3 years ago and published 100 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Fangdi Sun
2. Vincent Rajkumar
3. Ben Derman
4. Dr. Rachna Shroff
5. Dr. Julie Vose
6. Dr. Jorge Cortes
7. Dr. Harold Burstein
8. Rebecca Shatsky

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days